Search Results - "SEWELL, W. A"
-
1
Clinical uses of intravenous immunoglobulin
Published in Clinical and experimental immunology (01-10-2005)Get full text
Journal Article -
2
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe
Published in Frontiers in immunology (12-12-2014)“…The consumption of immunoglobulins (Ig) is increasing due to better recognition of antibody deficiencies, an aging population, and new indications. This review…”
Get full text
Journal Article -
3
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry
Published in International journal of laboratory hematology (01-10-2018)“…Introduction Immunophenotyping by flow cytometry is routinely employed in distinguishing between chronic lymphocytic leukemia (CLL) and mantle cell lymphoma…”
Get full text
Journal Article -
4
European consensus proposal for immunoglobulin therapies
Published in European journal of immunology (01-08-2014)“…The use of immunoglobulin (Ig) preparations (intravenous, IVIg, subcutaneous, SCIg) for replacement and immunomodulation therapy worldwide has tripled in the…”
Get full text
Journal Article -
5
Transitional B cell subsets in human bone marrow
Published in Clinical and experimental immunology (01-10-2013)“…Summary B cells originate from precursors in the bone marrow, and the first cells which migrate to the peripheral blood have been classified as ‘transitional B…”
Get full text
Journal Article -
6
Do ribosomopathies explain some cases of common variable immunodeficiency
Published in Clinical and experimental immunology (01-01-2011)“…The considerable clinical heterogeneity of patients with common variable immunodeficiency disorders (CVID) shares some similarity with bone-marrow failure…”
Get full text
Journal Article -
7
Antibody deficiency
Published in Journal of clinical pathology (01-09-2008)“…Antibody deficiencies may arise as primary disorders or secondary to a variety of diseases, drugs and other environmental/iatrogenic factors. Significant…”
Get more information
Journal Article -
8
Clinical Immunology Review Series: An approach to the use of the immunology laboratory in the diagnosis of clinical allergy
Published in Clinical and experimental immunology (01-07-2008)“…In the last 10 years UK immunology laboratories have seen a dramatic increase in the number and range of allergy tests performed. The reasons for this have…”
Get full text
Journal Article -
9
Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia
Published in Journal of clinical pathology (01-05-2009)“…The appropriate testing strategy for diagnosing pernicious anaemia using gastric parietal cell (GPC) and/or intrinsic factor antibodies (IFA) is controversial…”
Get more information
Journal Article -
10
IgE Sequences in Individuals Living in an Area of Endemic Parasitism Show Little Mutational Evidence of Antigen Selection
Published in Scandinavian journal of immunology (01-05-2011)“…Patterns of somatic mutation in IgE genes from allergic individuals have been a focus of study for many years, but IgE sequences have never been reported from…”
Get full text
Journal Article -
11
Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases
Published in Immunity (Cambridge, Mass.) (16-06-2015)“…The autoimmune regulator (AIRE) gene is crucial for establishing central immunological tolerance and preventing autoimmunity. Mutations in AIRE cause a rare…”
Get full text
Journal Article -
12
British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021
Published in British journal of dermatology (1951) (01-03-2022)“…Plain language summary available online…”
Get full text
Journal Article -
13
Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema
Published in Clinical Immunology (01-04-2007)“…Abstract The association of systemic lupus erythematosus and hereditary angioedema (HAE) has formed the basis of numerous case reports and is hypothesised to…”
Get full text
Journal Article -
14
Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X‐linked agammaglobulinaemia
Published in Clinical and experimental immunology (01-09-2000)“…Absolute and relative NK cell numbers were determined in peripheral whole blood by flow cytometry in patients with common variable immunodeficiency (CVID) (n =…”
Get full text
Journal Article -
15
Some cases of common variable immunodeficiency may be due to a mutation in the SBDS gene of Shwachman-Diamond syndrome
Published in Clinical and experimental immunology (01-03-2008)“…Known genetic defects currently account for only a small proportion of patients meeting criteria for 'probable' or 'possible' common variable immunodeficiency…”
Get full text
Journal Article -
16
The clinical significance of antinucleolar antibodies
Published in Journal of clinical pathology (01-03-2008)“…The importance of antinucleolar antibodies seen by indirect immunofluorescence on HEp-2 cells, although associated with systemic sclerosis (SSc), in unselected…”
Get more information
Journal Article -
17
A two-phase pathogenesis of graft-versus-host disease in mice
Published in Bone marrow transplantation (Basingstoke) (2002)“…Activation of donor T cells is required for the development of graft-versus-host disease (GVHD), a major complication of bone marrow transplantation. We…”
Get full text
Journal Article -
18
Therapeutic strategies in common variable immunodeficiency
Published in Drugs (New York, N.Y.) (01-01-2003)“…The treatment of common variable immunodeficiency (CVID) is currently based on the early recognition of the condition and replacement immunoglobulin combined…”
Get full text
Journal Article -
19
Oral immunosuppressive drugs
Published in Clinical medicine (London, England) (01-07-2006)Get full text
Journal Article -
20
Immunomodulatory action of intravenous immunoglobulin
Published in Immunology (01-12-2002)“…Intravenous immunoglobulin (IVIg) is a blood product prepared from the serum of between 1000 and 15 000 donors per batch. It is the treatment of choice for…”
Get full text
Journal Article